ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,582Medicare Part D Prescriptions Filled, Including Refills

Rank: 136 out of 680

$739K Total Retail Price of All Prescriptions

Rank: 145 out of 680

332 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 332 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

15% of this provider’s 332 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 12,259 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 452 394 1 2
SIMVASTATIN 380 364 2 3
AMLODIPINE BESYLATE 373 352 3 1
HYDROCODONE-ACETAMINOPHEN 313 238 S3 4 4
LISINOPRIL 292 249 5 5
METFORMIN HCL 272 247 6 8
GABAPENTIN 267 228 7 15
CARVEDILOL 249 227 8 23
PRAVASTATIN SODIUM 248 213 9 10
DIOVAN 234 219 10 31
OMEPRAZOLE 226 200 11 7
ZOLPIDEM TARTRATE 224 200 12 17
FUROSEMIDE 220 206 13 6
POTASSIUM CHLORIDE 212 179 14 14
TRAMADOL HCL 210 191 15 18
GLIMEPIRIDE 208 192 16 29
CLOPIDOGREL 206 182 17 26
SERTRALINE HCL 204 189 18 28
CRESTOR 200 180 19 25
RANITIDINE HCL 198 181 20 56
CITALOPRAM HBR 175 158 21 22
NEXIUM 174 156 22 16
FLUTICASONE PROPIONATE 169 155 23 41
LOSARTAN POTASSIUM 166 147 24 21
PLAVIX 156 140 25 39
DIOVAN HCT 148 136 26 55
HYDROCHLOROTHIAZIDE 144 140 27 9
METOPROLOL TARTRATE 141 124 28 12
MELOXICAM 141 124 28 24
ATENOLOL 138 134 30 19
LOVASTATIN 134 116 31 44
ATORVASTATIN CALCIUM 131 114 32 11
BISOPROLOL FUMARATE 131 120 32 173
DONEPEZIL HCL 124 124 34 27
FAMOTIDINE 122 113 35 89
AMLODIPINE BESYLATE-BENAZEPRIL 118 106 36 43
PANTOPRAZOLE SODIUM 115 111 37 30
WARFARIN SODIUM 109 94 38 20
CLONIDINE HCL 108 100 39 36
METOPROLOL SUCCINATE 108 104 39 13
LANTUS 108 88 39 49
ALENDRONATE SODIUM 107 107 42 32
DILTIAZEM 24HR ER 104 104 43 132
SINGULAIR 102 97 44 91
SYNTHROID 96 96 45 38
NAMENDA 93 93 46 35
TAMSULOSIN HCL 89 78 47 34
LYRICA 84 77 48 77
MONTELUKAST SODIUM 80 78 49 157
PREDNISONE 77 73 50 50
ALLOPURINOL 77 75 50 33
CLOTRIMAZOLE-BETAMETHASONE 74 69 52 138
ALPRAZOLAM 72 72 53 72
PROAIR HFA 71 62 54 67
ISOSORBIDE MONONITRATE ER 71 71 54 59
VENLAFAXINE HCL ER 63 31 56 101
BENAZEPRIL HCL 63 45 56 40
TRAMADOL HCL-ACETAMINOPHEN 62 62 58 153
SOTALOL 60 48 59 226
VERAPAMIL ER 58 55 60 100
LIPITOR 57 51 61 68
LOSARTAN-HYDROCHLOROTHIAZIDE 56 56 62 51
ESCITALOPRAM OXALATE 56 54 62 45
NIFEDIPINE ER 55 51 64 75
CYMBALTA 53 35 65 46
BENICAR 53 41 65 131
BENICAR HCT 53 38 65 150
ESTRADIOL 53 42 R 65 134
LOVAZA 52 48 69 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 17, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.